Hologic, Inc.
HOLX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$16.97B
Close$
Earnings Call Q2 2023
May 1, 2023 - AI Summary
Hologic reported strong financial results for the second quarter of fiscal 2023, with total revenue of $1.03 billion and non-GAAP earnings per share of $1.06, both exceeding expectations.
The company's organic revenue, excluding COVID, grew 21.9%, driven by strong performance in Diagnostics (14.9% growth), Surgical (25.2% growth), and Breast Health (25.7% growth).
Hologic reaffirmed its guidance for low double-digit organic revenue growth for each division in fiscal 2023, excluding COVID. However, they acknowledged that tougher comps in the third quarter may impact future growth rates.
Exclusive for Stockcircle Pro members
Sign up
$129.68
70.6% upside
Current Fair Value
70.6% upsideUndervalued by 70.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $16.97 Billion |
|---|---|
| Enterprise Value | $15.02 Billion |
| Earnings per Share | $2.5 |
| Beta | 0.7 |
| Outstanding Shares | 224,405,000 |
Return
| Return on Equity | 10.37% |
|---|---|
| Return on Assets | 5.92% |
| Return on Invested Capital | 8.80% |
Valuation & Multiples
| P/E Ratio | 30.28 |
|---|---|
| PEG | -277.94 |
| Price to Sales | 5.85 |
| Price to Book Ratio | 3.3 |
| Enterprise Value to Revenue | 4.84 |
| Enterprise Value to EBIT | 20.74 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Last Earnings Call
Report Date
May 7, 2026
EPS Estimate
$1.09
Consensus analyst estimateRevenue Estimate
$1.03 B
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 5.08, the ratio is above 1, so institutions hold more puts than calls. That is a more cautious stance.
| Put/Call Ratio | 5.0823▼ 43.17% |
|---|---|
| Total Calls | 390,100▲ 127.60% |
| Total Puts | 1,982,600▲ 109.78% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 95.98%▲ 0.22% |
|---|---|
| Total Invested | $16.28B▲ 1.62% |
| Investors Holding | 730▼ 43.00% |
About Hologic, Inc.
6,478 employees
CEO: Stephen MacMillan
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.